Dyne Therapeutics (NASDAQ:DYN – Free Report) had its price objective decreased by JPMorgan Chase & Co. from $18.00 to $17.00 ...
Verastem (NASDAQ:VSTM – Free Report) had its price objective cut by Royal Bank of Canada from $16.00 to $14.00 in a report released on Friday morning,Benzinga reports. They currently have an ...
The Canadian Press on MSN22h
The climate indicator banks are facing rising pressure to reportWhen Canada’s big banks left the Net Zero Banking Alliance earlier this year, they assured they could push on reducing ...
In this Sunday edition of BI Today, we're talking about Tesla's 9 weeks of pain.
US stock futures rose, as last week's reversal of four consecutive weeks of losses in the major gauges held strong.
Large fund managers expect the bulk of Russia's assets to remain closed to Western investors, despite a flurry of "exotic" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results